Overexpression of S100A4 is closely associated with the progression and prognosis of gastric cancer in young patients

Oncology Letters

Volumn 5, Issue 5, 2013, Pages 1485-1490

  Li, Hua ^a   Liu, Ziquan ^b,c   Xu, Chuanxiang ^b   Chen, Yunyun ^b   Zhang, Jianwei ^b   Cui, Bo ^b   Chen, Xuewei ^b   An, Gaihong ^b   She, Xiaojun ^b   Liu, Hongtao ^b   Jiang, Zifeng ^d   Wang, Tianhui ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF HEALTH AND ENVIRONMENTAL MEDICINE   (China)

^c MEDICAL COLLEGE OF CHINESE PEOPLE'S ARMED POLICE FORCES   (China)

^d INSTITUTE OF ZOOLOGY   (China)

Author keywords

Gastric cancer; Immunohistochemistry; Prognosis; Progression; S100A4; Young patients

Indexed keywords

CALVASCULIN; MESSENGER RNA;

ADULT; ARTICLE; CANCER GROWTH; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; FOLLOW UP; GENE OVEREXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PROTEIN EXPRESSION; RADIODIAGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM; STOMACH ADENOCARCINOMA; STOMACH CANCER; STOMACH MUCOSA; SURVIVAL RATE; TUMOR VOLUME; UPREGULATION;

EID: 84875718348     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1220     Document Type: Article

References (20)

1. Kamangar F, Dores GM and Anderson WF: Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24: 2137-2150, 2006.
2. Simsa J, Leffler J, Hoch J, et al: Gastric cancer in young patients-is there any hope for them. Acta Chir Belg 104: 673-676, 2004.
3. Chen CY, Wu CW, Lo SS, et al: Peritoneal carcinomatosis and lymph node metastasis are prognostic indicators in patients with Borrmann type IV gastric carcinoma. Hepatogastroenterology 49: 874-877, 2002.
4. Fareed KR, Kaye P, Soomro IN, et al: Biomarkers of response to therapy in oesophago-gastric cancer. Gut 58: 127-143, 2009.
5. Garrett SC, Varney KM, Weber DJ and Bresnick AR: S100A4, a mediator of metastasis. J Biol Chem 281: 677-680, 2006.
6. Matsumoto K, Irie A, Satoh T, et al: Expression of S100A2 and S100A4 predicts for disease progression and patient survival in bladder cancer. Urology 70: 602-607, 2007.
7. Sack U, Walther W, Scudiero D, et al: Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer. J Natl Cancer Inst 103: 1018-1036, 2011.
8. Kikuchi N, Horiuchi A, Osada R, et al: Nuclear expression of S100A4 is associated with aggressive behavior of epithelial ovarian carcinoma: an important autocrine/paracrine factor in tumor progression. Cancer Sci 97: 1061-1069, 2006.
9. Lee OJ, Hong SM, Razvi MH, et al: Expression of calcium-binding proteins S100A2 and S100A4 in Barrett's adenocarcinomas. Neoplasia 8: 843-850, 2006.
10. Flatmark K, Pedersen KB, Nesland JM, et al: Nuclear localization of the metastasis-related protein S100A4 correlates with tumour stage in colorectal cancer. J Pathol 200: 589-595, 2003.
11. Medina-Franco H, Heslin MJ and Cortes-GonzaleR: Clinicopathological characteristics of gastric carcinoma in young and elderly patients: a comparative study. Ann Surg Oncol 7: 515-519, 2000.
12. Wang YY, Ye ZY, Zhao ZA, et al: High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer. Ann Surg Oncol 17: 89-97, 2010.
13. Cho YG, Nam SW, Kim TY, et al: Overexpression of S100A4 is closely related to the aggressiveness of gastric cancer. APMIS 111: 539-545, 2003.
14. Yonemura Y, Endou Y, Kimura K, et al: Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer. Clin Cancer Res 6: 4234-4242, 2000.
15. Chung HW, Noh SH and Lim JB: Analysis of demographic characteristics in 3242 young age gastric cancer patients in Korea. World J Gastroenterol 16: 256-263, 2010.
16. Kim DY, Joo JK, Ryu SY, et al: Clinicopathologic characteristics of gastric carcinoma in elderly patients: A comparison with young patients. World J Gastroenterol 11: 22-26, 2005.
17. Chung HW, Park SW, Chung JB, et al: Differences in genetic expression profiles between young-age and old-age gastric adenocarcinoma using cDNA microarray for endocrine disruptor study. Oncol Rep 12: 33-39, 2004.
18. Ershler WB and Longo DL: The biology of aging: the current research agenda. Cancer 80: 1284-1293, 1997.
19. Masuda G, Tokunaga A, Shirakawa T, et al: Helicobacter pylori infection, but not genetic polymorphism of CYP2E1, is highly prevalent in gastric cancer patients younger than 40 years. Gastric Cancer 10: 98-103, 2007.
20. Kokkola A, Valle J, Haapiainen R, et al: Helicobacter pylori infection in young patients with gastric carcinoma. Scand J Gastroenterol 31: 643-647, 1996.